Oral candidosis and its role in immunocompromised patients.
The increased incidence of invasive candidosis in numerous categories of patients, including neonates, cancer patients, AIDS patients and patients who have undergone organ transplantation, is of great concern for the physicians involved. The manifestations of candidosis are numerous, and various clinical entities such as localized and disseminated infection have to be considered separately. All types of localized candidosis per se are usually not the main cause of disseminated disease. However, spreading of the mycotic pathogens in the gastrointestinal tract could induce disseminated candidosis. Prophylactic measurements in risk patients and consequent local and, if necessary, systemic treatment is recommended in these clinical entities.
Lode
H
H
Höffken
G
G
D002180:Candidiasis, Oral / Q000150:complications / Q000276:immunology*; D002908:Chronic Disease; D006801:Humans; D007108:Immune Tolerance; D009894:Opportunistic Infections / Q000150:complications / Q000276:immunology*